Evidence map›Paper›PMID 22865632›Full record

ArticleInternational journal of cancer2013

Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer.

Rong Wang, Christiane V Löhr, Kay Fischer, W Mohaiza Dashwood, Jeffrey A Greenwood, Emily Ho, David E Williams, Hassan Ashktorab, Michael R Dashwood, Roderick H Dashwood

Abstract read
In one paragraph

Article in International journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer.Journal of cancer research and clinical oncology · 2023
    Article
  3. Article
  4. Methylation-mediated silencing ofFrontiers in oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Epigenetic silencing of endothelin-3 in colorectal cancer.International journal of immunopathology and pharmacology · 2016
    Article
  20. Endothelin.Pharmacological reviews · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Rong WangLinus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA.
Christiane V Löhr
Kay Fischer
W Mohaiza Dashwood
Jeffrey A Greenwood
Emily Ho
David E Williams
Hassan Ashktorab
Michael R Dashwood
Roderick H Dashwood
Oregon State University · USHoward University · USUniversity College London · GB

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
STRUCTURAL/FUNCTIONAL CHARACTERIZATION OF AMINOGLYCOSIDEG12RR003048 · NCRR · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 1985 to 2011
$19.0M
Transplacental Chemoprevention of Lung Tumors and LymphomasP01CA090890 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DASHWOOD, RODERICK H · 2003 to 2014
$14.2M
Dietary HDAC Inhibitors in Colon Cancer PreventionR01CA122959 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DASHWOOD, RODERICK H · 2008 to 2023
$4.3M
Dietary histone deactylase inhibitors in prostate cancer preventionR01CA122906 · NCI · OREGON STATE UNIVERSITY · PI HO, EMILY · 2007 to 2011
$2.0M
Modulation of Colon Carcinogenesis by ChlorophyllinR01CA065525 · NCI · OREGON STATE UNIVERSITY · PI DASHWOOD, RODERICK H · 2004 to 2008
$1.5M
BETA CATENIN MUTATION IN PHIP AND IQ INDUCED COLON CAR01CA080176 · NCI · OREGON STATE UNIVERSITY · PI DASHWOOD, RODERICK H · 2000 to 2004
$1.3M
MODULATION OF COLON CARCINOGENESIS BY CHLOROPHYLLINR29CA065525 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI DASHWOOD, RODERICK H · 1996 to 2000
$99k
NCI NIH HHS CA090890NCI NIH HHS CA122906NCI NIH HHS CA122959NCI NIH HHS CA65525NCI NIH HHS CA80176NCI NIH HHS P01 CA090890NCI NIH HHS R01 CA065525NCI NIH HHS R01 CA080176NCI NIH HHS R01 CA122906NCI NIH HHS R01 CA122959NCI NIH HHS R29 CA065525NCRR NIH HHS G12 RR003048NIEHS NIH HHS ES00210NIEHS NIH HHS P30 ES000210
6 · The paper itself

Abstract

Endothelin-1 (ET-1) and its receptors are overexpressed in human cancers, but much less is known about the roles of ET-2 and ET-3 in cancer etiology. We sought to examine human and rat colon tumors for dysregulation of ET-2 and ET-3 expression and determine the underlying mechanisms. Human primary colon cancers and carcinogen-induced rat colon tumors were subjected to real-time RT-PCR, immunoblotting and immunohistochemistry; EDN2 and EDN3 genes were examined by methylation-specific PCR, bisulfite sequencing and pyrosequencing; and forced expression of ET-2 and ET-3 was conducted in human colon cancer cells followed by real-time cell migration and invasion assays. Rat and human colon tumors had markedly reduced expression of ET-2 and ET-3 mRNA and protein compared with matched controls. Mechanistic studies revealed hypermethylation of EDN2 and EDN3 genes in human primary colon cancers and in a panel of human colon cancer cell lines. Forced expression of ET-2 and ET-3 attenuated significantly the migration and invasion of human colon cancer cells. We conclude that epigenetic inactivation of ET-2 and ET-3 occurs frequently in both rat and human colon cancers. Current therapeutic strategies target overexpressed members of the ET axis via small molecule inhibitors and receptor antagonists, but this work supports a complementary approach based on the re-expression of ET-2 and ET-3 as natural antagonists of ET-1 in colon cancer.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsCaco-2 CellsCell Line, TumorCell MovementColonic NeoplasmsDNA MethylationEndothelin-2Endothelin-3Epigenesis, GeneticEpigenomicsGene SilencingHCT116 CellsHT29 CellsHumansImmunohistochemistryEndothelin-2Endothelin-3RNA, Messenger

Identifiers

PMID22865632
PMCPMC3500448
OpenAlexW2033185380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.